{
    "clinical_study": {
        "@rank": "100915", 
        "arm_group": [
            {
                "arm_group_label": "Critically ill patients admitted to ICU", 
                "description": "those patients who are admitted to ICU with multiorgan failure/injury"
            }, 
            {
                "arm_group_label": "Neutropinc Fever patients", 
                "description": "admitted to ER, haemato-oncology or oncology"
            }, 
            {
                "arm_group_label": "Patients of Hip's  Fracture", 
                "description": "admitted to orthopedic departement"
            }
        ], 
        "biospec_descr": {
            "textblock": "blood and serum"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Immature Platelet Fraction (IPF) is a new value in CBC blood tests Recent Studies showed\n      that this value may be another prognostic factor in critically ill patients such as those\n      admitted to ICU, or those with neutropenic Fever.\n\n      The purpose of the study is to check if the IPF may be used as a prognostic Factor in these\n      patients"
        }, 
        "brief_title": "Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Critically Ill Patients", 
            "Neutropenic Fever Patients", 
            "Patients With Hip Fractures"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Critical Illness", 
                "Fever", 
                "Fractures, Bone", 
                "Hip Fractures", 
                "Neutropenia"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this study we have 3 groups of patients\n\n        -  Patients admitted to ICU\n\n        -  Patients admitted with neutropenic fever\n\n        -  Patients admitted with hip fractures it is a prospective study, not interventional,\n           we'll take blood samples of these patients including CBC count eith IPF and other\n           inflammation markers such as CRP and we'll compare CRP to IPF in addition to clinical\n           follow-up of the patient till discharge.\n\n      At the end of this study we'll compare the efficacy of IPF as a prognostic Factor in these\n      patients"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Admission to hospital blood sample is taken between 24:00 pm till 15:00 pm\n\n        Exclusion Criteria:\n\n          -  blood sample is taken after 15:00 pm in the first day of admission during the week\n\n          -  blood sample is taken on weekend: thursday 15:00 pm till saturday 24:00 pm"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "admmitted patients to multiple departements"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02016859", 
            "org_study_id": "IPF-2013-Rambam"
        }, 
        "intervention": {
            "arm_group_label": [
                "Critically ill patients admitted to ICU", 
                "Neutropinc Fever patients", 
                "Patients of Hip's  Fracture"
            ], 
            "intervention_name": "Immature Platelet Fraction", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "IPF Immature platelet fraction", 
            "ICU neutropenic fever", 
            "hip fracture", 
            "critically ill"
        ], 
        "lastchanged_date": "December 15, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel"
                }, 
                "name": "Rambam Health care campus"
            }, 
            "status": "Active, not recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "3", 
        "other_outcome": {
            "description": "this outcome is not uet based we need much more studies in order to be able to use IPF in daily clinical work", 
            "measure": "clinical use of IPF as a prognostic factor", 
            "safety_issue": "No", 
            "time_frame": "up to 12 months"
        }, 
        "overall_contact": {
            "email": "Y_ofran@ramabm.health.gov.il", 
            "last_name": "Yishai Ofran, Doctor", 
            "phone": "009720502061524"
        }, 
        "overall_contact_backup": {
            "email": "d_okasha@rambam.health.gov.il", 
            "last_name": "Doaa Okasha, doctor", 
            "phone": "009720502062701"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Helsinki Commitee-Rambam Medical Center", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the primary outcome is the result of the patient's admission on which data analysis will be based", 
            "measure": "Time to recovery from sepsis or time to death", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02016859"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rambam Health Care Campus", 
            "investigator_full_name": "Dr. Yishai Ofran", 
            "investigator_title": "Doctor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "after the analysis of the data we'll may ba able to assess the predicting value of the IPF in predicting severity of infection and prediciting prognosis of infection in the three groups described", 
            "measure": "Predicting value of IPF for prognosis", 
            "safety_issue": "No", 
            "time_frame": "baeline 6 months"
        }, 
        "source": "Rambam Health Care Campus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Yishai Ofran", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "6 Months", 
        "verification_date": "December 2013"
    }
}